Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis. - Wikidata - wikimedia - TriplyDB

Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis.

Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis.

http://www.wikidata.org/entity/Q37620992

about

The Impact of Hemodialysis Frequency and Duration on Blood Pressure Management and Quality of Life in End-Stage Renal Disease Patients.

P2860

Q41665538-E842A9D2-2DD2-4C0E-A33E-911F09278C54

P2860

Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis.

http://www.wikidata.org/entity/Q37620992

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical Implication of the Re ...... sease Undergoing Hemodialysis.

@en

Clinical Implication of the Re ...... sease Undergoing Hemodialysis.

@nl

type

label

Clinical Implication of the Re ...... sease Undergoing Hemodialysis.

@en

Clinical Implication of the Re ...... sease Undergoing Hemodialysis.

@nl

prefLabel

Clinical Implication of the Re ...... sease Undergoing Hemodialysis.

@en

Clinical Implication of the Re ...... sease Undergoing Hemodialysis.

@nl

P1433

Q37620992-110FACB4-5D2C-40B5-9A80-21801770F32D

P1476

Q37620992-397A8C89-7DB1-4F5E-9719-6BFAED2FEB16

P2093

Q37620992-37C335B1-6302-4A69-8033-6C7E39C3B473

Q37620992-89E084B5-4433-4A96-A759-C2F473872556

Q37620992-C69E949E-B408-44A4-B188-B916DF0961A5

P2860

Q37620992-0276D170-57DE-4FAA-AE77-09FA074669C5

Q37620992-0A4C5CCD-B834-4F36-A629-11FA46F89657

Q37620992-17A63C21-6A5B-4A27-8F17-8EFB328F7EA3

Q37620992-1E3A6721-DDB2-43AF-AD11-08F90C5F5BD9

Q37620992-25B4B55C-E905-4BEA-AFC0-1E8AD4FECB05

Q37620992-263C5E54-3367-42D6-B6FC-1F55685934B1

Q37620992-27BAF5E9-B94D-420D-9FCB-CA83934A455D

Q37620992-2A743452-B28D-440A-945B-03957029786C

Q37620992-338011AA-DFAC-490A-B75B-280C92D2C801

Q37620992-3A431BB9-45F1-4218-909A-F3B408BB48E3

P304

Q37620992-2DC47AFE-4B30-4773-BBFC-34966DADD124

P31

Q37620992-17B4D533-ADFD-4844-B9D6-5A8E4F3E2EE2

P356

Q37620992-50D49CA1-3E5D-4D5A-BE54-A87FE60C9809

P478

Q37620992-5ACE05F1-48AB-425D-B1B1-F8076151995A

P577

Q37620992-AB75BD21-6A84-4C81-B2D0-15B6E48490BD

P5875

Q37620992-63FBD4F2-DC98-4E9A-A90A-953E9740A0DD

P698

Q37620992-E75C9851-9D75-4115-A943-0BEB972A19CD

P932

Q37620992-543DFECF-0507-41CB-AF7F-CB1B6BA7F347

P356

1874192401408010006

P1433

Open Cardiovascular Medicine Journal

P1476

Clinical Implication of the Re ...... sease Undergoing Hemodialysis.

@en

P2093

Daisuke Nagata

http://www.w3.org/2001/XMLSchema#string

Eiji Kusano

http://www.w3.org/2001/XMLSchema#string

Yoshiyuki Morishita

http://www.w3.org/2001/XMLSchema#string

P2860

Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin

United States Renal Data System assessment of the impact of the National Kidney Foundation-Dialysis Outcomes Quality Initiative guidelines.

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials

Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis.

Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes.

Long-term effects of aliskiren on blood pressure and the renin-angiotensin-aldosterone system in hypertensive hemodialysis patients

Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients.

Action of irbesartan on blood pressure and glucose/lipid metabolism, in hemodialysis patients with hypertension.

Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis

Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline

P304

6-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1874192401408010006

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260647538

http://www.w3.org/2001/XMLSchema#string

P698

24611082

http://www.w3.org/2001/XMLSchema#string

P932

3944431

http://www.w3.org/2001/XMLSchema#string